Mass Spectrometry-Based Proteomics
JPT supports the proteomics community with tools for discovery, targeted and clinical proteomics. The needs of researchers for inexpensive, heavily labeled or unlabeled and absolutely quantified peptides triggered the development of the SpikeTides™ and SpikeTides™_TQL technologies, which find widespread application in many laboratories. Our Bioinformatics expertise allows for intelligent peptide library design that, in combination with our technologies, helps to solve complex problems in target discovery and validation as well as biomedical research.
JPT's SpikeTides™ :
- SpikeTides™ are cost-effective
- They allow high-speed SRM assay and MRM assay development
- Use for protein quantitation with almost unlimited coverage through entire proteomes
- Thousands of proteotypic SpikeTides™ can be prepared at unmatched turnaround times (10 000 peptides per week)
- SpikeTides™ also enable the monitoring of cellular regulation by incorporation of post-translational modifications
- Absolute quantified SpikeTides™TQL use a new approach for absolute quantification that is significantly more cost effective than using traditional AAA quantified standard peptides
- Absolute quantified SpikeTides™ TQL PLUS allow for up-to-date quantification immediately before experiment for clinical applications
- SpikeTides™ also enable the monitoring of cellular regulation by incorporation of post-translational modifications
